Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

TSX:QIPT - Post Discussion

Quipt Home Medical Corp > Weight loss drugs impacting CPAP…
View:
Post by SR71BlackBird on Sep 06, 2023 8:46am

Weight loss drugs impacting CPAP…

How real is this a threat? Is this why it dropped down late yesterday afternoon? Thoughts?


IMO

Comment by SR71BlackBird on Sep 06, 2023 8:50am
ResMed has been hammered because of this. Just wondering, does it trickle on to us. IMO. 
Comment by Carlito3311 on Sep 06, 2023 8:52am
This post has been removed in accordance with Community Policy
Comment by Carlito3311 on Sep 06, 2023 8:53am
This post has been removed in accordance with Community Policy
Comment by besttobe on Sep 06, 2023 9:50am
Maybe this new drug is "one" the reasons the nastaq shorts are so high for both Quipt and VMD. The next short report should be telling.  We shall see....
Comment by aswall2 on Sep 06, 2023 10:00am
you are lying again   "so high for both Quipt and VMD" on Maket beat:  qipt short % of float  = 1,75% and vmd= 1,60% Is that what you call High....???   lollllllll  
Comment by SR71BlackBird on Sep 06, 2023 10:28am
I think this is simply the next, and latest reason that this thing crashes. Hurts to say it but history says this is what's going to happen. IMO. 
Comment by westcoastlogger on Sep 06, 2023 9:55am
This so-called miracle drug is expensive and has to be used continually to keep the flab off so I can foresee the flab winning. People are addicted to Doritos and pizza and chicken wings so there you go.
Comment by Carlito3311 on Sep 06, 2023 9:59am
This post has been removed in accordance with Community Policy
Comment by Carlito3311 on Sep 06, 2023 10:08am
This post has been removed in accordance with Community Policy
Comment by besttobe on Sep 06, 2023 10:19am
Carlito3311 wrote 'We will find out soon based on buyer interest for Rotech and what the valuation is that they actually get a deal done at." Hard to say what Rotech is worth, as it is a private company and they don't release financials. Do you have any idea what their sales are? 
Comment by HatrikSeLaine on Sep 06, 2023 11:54am
Oh yes, for sure Ozempic is going to result in the plummeting of QIPT.   After all, your typical middle class American has loads of Medical Insurance with low premiums and high drug cost coverage.   That same dude is going to also; love jabbing themselves in the stomach every week, suddenly give up smoking/vaping tomorrow and of course will never dabble in fast food, alcohol or lead a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities